|
AU594014B2
(en)
|
1984-03-21 |
1990-03-01 |
Research Corporation Technologies, Inc. |
Recombinant DNA molecules
|
|
CA1282721C
(en)
|
1984-06-04 |
1991-04-09 |
Bernard Roizman |
Herpes simplex virus as a vector
|
|
US5288641A
(en)
|
1984-06-04 |
1994-02-22 |
Arch Development Corporation |
Herpes Simplex virus as a vector
|
|
EP0173552B1
(en)
|
1984-08-24 |
1991-10-09 |
The Upjohn Company |
Recombinant dna compounds and the expression of polypeptides such as tpa
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
US5698531A
(en)
|
1989-03-31 |
1997-12-16 |
The Regents Of The University Of Michigan |
Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
|
|
US5328688A
(en)
|
1990-09-10 |
1994-07-12 |
Arch Development Corporation |
Recombinant herpes simplex viruses vaccines and methods
|
|
US6770274B1
(en)
|
1990-09-14 |
2004-08-03 |
The General Hospital Corporation |
Viral mutant HSV mediated destruction of neoplastic cells
|
|
US6040169A
(en)
|
1991-01-31 |
2000-03-21 |
Medical Research Council |
Herpes simplex virus-1 deletion variants and vaccines thereof
|
|
ES2183811T3
(es)
|
1992-03-31 |
2003-04-01 |
Arch Dev Corp |
Tratamiento de enfermedades tumorigenas con un hsv modificado.
|
|
US6699468B1
(en)
|
1994-06-23 |
2004-03-02 |
Georgetown University |
Replication-competent herpes simplex virus mediates destruction of neoplastic cells
|
|
WO1997012623A1
(en)
|
1995-10-06 |
1997-04-10 |
Arch Development Corporation |
Methods and compositions for viral enhancement of cell killing
|
|
US5824318A
(en)
|
1996-07-24 |
1998-10-20 |
American Cyanamid Company |
Avirulent herpetic viruses useful as tumoricidal agents and vaccines
|
|
GB9700411D0
(en)
*
|
1997-01-10 |
1997-02-26 |
Univ London |
Eukaryotic gene expression cassette and uses thereof
|
|
US6379674B1
(en)
|
1997-08-12 |
2002-04-30 |
Georgetown University |
Use of herpes vectors for tumor therapy
|
|
US7300774B1
(en)
|
1999-12-09 |
2007-11-27 |
The Regents Of The University Of California |
Multimeric fusion proteins of the TNF superfamily ligands
|
|
US6428968B1
(en)
|
1999-03-15 |
2002-08-06 |
The Trustees Of The University Of Pennsylvania |
Combined therapy with a chemotherapeutic agent and an oncolytic virus for killing tumor cells in a subject
|
|
EP1955703A1
(en)
|
1999-11-12 |
2008-08-13 |
Oncolytics Biotech Inc. |
Viruses for the treatment of cellular proliferative disorders
|
|
DE60115600T2
(de)
|
2000-01-21 |
2006-07-20 |
Biovex Ltd. |
Virusstämme für die onkolytische behandlung von krebs
|
|
CA2441663C
(en)
|
2001-03-27 |
2013-01-22 |
Medigene, Inc. |
Viral vectors and their use in therapeutic methods
|
|
GB0317511D0
(en)
*
|
2003-07-25 |
2003-08-27 |
Biovex Ltd |
Viral vectors
|
|
US7731952B2
(en)
|
2004-06-24 |
2010-06-08 |
New York University |
Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
|
|
RU2007114111A
(ru)
|
2004-11-04 |
2008-12-10 |
Пфайзер Продактс Инк. (Us) |
Лечение рака молочной железы с помощью комбинации антитела против ctla4 и ингибитора ароматазы
|
|
EP1871806A2
(en)
|
2005-03-08 |
2008-01-02 |
Pharmacia & Upjohn Company LLC |
ANTI-MAdCAM ANTIBODY COMPOSITIONS
|
|
CN101495126B
(zh)
|
2005-06-23 |
2016-01-06 |
休斯顿大学 |
Ⅱ型单纯疱疹病毒突变体在治疗癌症中的用途
|
|
GB0522476D0
(en)
|
2005-11-03 |
2005-12-14 |
Biovex Ltd |
Oncolytic herpes virus vectors
|
|
JP6092497B2
(ja)
|
2006-03-30 |
2017-03-08 |
ユニバーシティー オブ カリフォルニア |
抗ｃｔｌａ−４抗体の限局性分泌のための方法および組成物
|
|
EP2307033A4
(en)
|
2008-05-29 |
2012-06-13 |
Gen Hospital Corp |
USE OF ONCOLYTIC HERPESVIRUS FOR THE KILLING OF CANCER STEM CELLS
|
|
CN102575227A
(zh)
|
2008-10-08 |
2012-07-11 |
英特瑞克斯顿股份有限公司 |
表达多种免疫调节剂的工程改造细胞及其应用
|
|
US20100297072A1
(en)
|
2009-05-19 |
2010-11-25 |
Depinho Ronald A |
Combinations of Immunostimulatory Agents, Oncolytic Virus, and Additional Anticancer Therapy
|
|
WO2011063309A1
(en)
|
2009-11-20 |
2011-05-26 |
Infinity Pharmaceuticals, Inc. |
Methods and compositions for treating hedgehog-associated cancers
|
|
WO2011119925A2
(en)
|
2010-03-25 |
2011-09-29 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Synthetic herpes simplex viruses for treatment of cancers
|
|
WO2011118866A1
(ko)
|
2010-03-26 |
2011-09-29 |
연세대학교 산학협력단 |
네트워크를 통한 심사요청 방법
|
|
KR20130108371A
(ko)
|
2010-09-24 |
2013-10-02 |
온코스 테라퓨틱스 오와이 |
단클론 항―ｃｔｌａ－４ 항체를 암호화하는 종양분해 아데노바이러스 벡터
|
|
FI20115914A7
(fi)
|
2011-09-16 |
2013-03-17 |
Oncos Therapeutics Ltd |
Muunnettu onkolyyttinen virus
|
|
DK2806883T3
(da)
|
2012-01-25 |
2019-07-22 |
Dnatrix Inc |
Biomarkører og kombinationsterapier under anvendelse af onkolytisk virus og immunomodulation
|
|
CA2877414A1
(en)
*
|
2012-07-30 |
2014-02-06 |
Alex Wah Hin Yeung |
Live and in-vivo tumor specified cancer vaccine system
|
|
JP6457940B2
(ja)
|
2012-08-30 |
2019-01-23 |
アムジエン・インコーポレーテツド |
単純ヘルペスウイルスおよび免疫チェックポイント阻害薬を使用して、メラノーマを治療するための方法
|
|
US9789182B2
(en)
*
|
2012-10-23 |
2017-10-17 |
Bristol-Myers Squibb Company |
Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer
|
|
EP2958592A1
(en)
|
2013-02-22 |
2015-12-30 |
F. Hoffmann-La Roche AG |
Methods of treating cancer and preventing drug resistance
|
|
EA038981B1
(ru)
|
2013-03-14 |
2021-11-17 |
Икан Скул Оф Медсин Эт Маунт Синай |
Вирусы болезни ньюкасла и их применение
|
|
WO2015032755A1
(en)
|
2013-09-03 |
2015-03-12 |
Medimmune Limited |
Compositions featuring an attenuated newcastle disease virus and methods of use for treating neoplasia
|
|
AU2014338864C1
(en)
*
|
2013-10-25 |
2020-07-16 |
Akamis Bio Limited |
Oncolytic adenoviruses armed with heterologous genes
|
|
CN106068326B
(zh)
*
|
2013-10-28 |
2021-06-18 |
联邦高等教育系统-匹兹堡大学 |
溶瘤性hsv载体
|
|
CA2931322A1
(en)
|
2013-11-22 |
2015-05-28 |
Dnatrix, Inc. |
Adenovirus expressing immune cell stimulatory receptor agonist(s)
|
|
US10933106B2
(en)
*
|
2014-02-25 |
2021-03-02 |
Deutsches Krebsforschungszentrum |
RNA viruses for immunovirotherapy
|
|
MA39818A
(fr)
|
2014-03-30 |
2017-02-08 |
Benevir Biopharm Inc |
Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
|
|
DK3169341T3
(da)
*
|
2014-07-16 |
2019-08-05 |
Transgene Sa |
Onkolytisk virus til ekspression af immun-checkpoint-modulatorer
|
|
AU2015289081B2
(en)
|
2014-07-16 |
2020-02-06 |
Transgene Sa |
Combination of oncolytic virus with immune checkpoint modulators
|
|
US20160040186A1
(en)
*
|
2014-08-07 |
2016-02-11 |
Xiaoyun Liu |
Dna construct and method for transgene expression
|
|
GB201419579D0
(en)
|
2014-11-03 |
2014-12-17 |
Iomet Pharma Ltd |
Pharmaceutical compound
|
|
CA2974529C
(en)
|
2015-01-23 |
2023-08-15 |
Dreamwell, Ltd. |
Automated mattress manufacturing process and apparatus
|
|
CN104987421A
(zh)
*
|
2015-05-13 |
2015-10-21 |
北京比洋生物技术有限公司 |
抗ctla-4和pd-1的双重可变结构域免疫球蛋白
|
|
EP3778881A1
(en)
*
|
2016-01-08 |
2021-02-17 |
Replimune Limited |
Modified oncolytic virus
|
|
KR102211838B1
(ko)
*
|
2016-04-22 |
2021-02-03 |
임비라 컴퍼니 리미티드 |
암치료용 종양 용해성 단순 헤르페스 바이러스(oHSV) 절대 벡터 및 그 구조체의 구조
|
|
GB201700350D0
(en)
|
2017-01-09 |
2017-02-22 |
Replimune Ltd |
Altered virus
|
|
US20210252135A1
(en)
*
|
2018-06-21 |
2021-08-19 |
Replimune Limited |
Treatment using oncolytic virus
|